Pushing the Limits of Cancer Detection
June 10 2014 - 9:00AM
Business Wire
Manhattan Scientifics
Delivers Break-Through Cancer Measuring Instrument to M.D. Anderson
Cancer Center
Technology Intended to
Find Cancers Years Earlier
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that
it has delivered its break-through, cancer measurement instrument
to The University of Texas M.D. Anderson Cancer Center in Houston,
TX.
On January 27th 2014, the company executed an agreement to
collaborate with M.D. Anderson to advance, demonstrate and validate
a breakthrough technology developed by Edward R. Flynn, PhD. Dr.
Flynn is the founder and chief scientist of the company’s
subsidiary, Senior Scientific LLC. Senior Scientific is seeking to
commercialize its patented technology using iron oxide
nanoparticles that bind with individual cancer cells which will
enable physicians to locate, identify and measure tumors thousands
of times smaller than otherwise detectable with current
technologies.
Manhattan Scientifics, Inc., together with the National
Institute of Health, financed the development and construction of
the new medical instrument. Management believes this new
technology, called magnetic relaxometry or MRX, will emerge as the
next important evolutionary step in cancer diagnostics; the next
step beyond X-ray, sonography, MRI, CT, and PET scanning. With many
types of cancers, very early detection is the key to successful
therapy and cure. For further information please refer to the
company's two websites listed below.
Dr. John D. Hazle, Professor and Chairman of the Department of
Imaging Physics, MD Anderson, said, “This is a truly exciting new
technology. With the system now located in our lab, our goal is to
fully exploit the capabilities and push the limits of
detectability. We are starting this scientific journey with ovarian
cancer where early detection continues to limit our ability to
effectively treat this disease. With new risk indicators, some
developed right here at M.D. Anderson, we hope to include MRX in a
new paradigm of early detection for ovarian and other cancers.”
About Manhattan Scientifics
Manhattan Scientifics Inc. (www.mhtx.com) is located in New
Mexico, New York and Montreal. It is focused on technology transfer
and commercialization of transformative technologies in the
nanomedicine space. The company is pursuing its "licensing"
business model. The company's ultra-fine grain metals titanium
application has been licensed to a Fortune/1000 NYSE company
positioning the company's Metallicum unit as cash flow
positive.
About Senior Scientific
Senior Scientific (www.seniorscientific.com) facilities are
located at the University of New Mexico Science and Technology Park
in Albuquerque, New Mexico. The company has developed a novel
bioimaging and nanomagnetic detection systems to detect cancer and
other diseases earlier and with higher specificity than is
currently possible. The technology makes possible the earlier
detection of cancer in vivo, the ability to analyze biopsies with
greater sensitivity and accuracy, the ability to monitor the
therapeutic effectiveness of anticancer treatments—both in humans
and in animal models—and allows it to detect cancer recurrence with
significantly improved sensitivity.
Forward-looking statement
This press release contains forward-looking statements which are
subject to a number of risks, assumptions and uncertainties that
could cause the Company's actual results to differ materially from
those projected in such forward-looking statements. Management at
Manhattan Scientifics believes that purchase of its shares should
be considered to be at the high end of the risk spectrum.
Forward-looking statements speak only as of the date made and are
not guarantees of future performance. We undertake no obligation to
publicly update or revise any forward-looking statements.
Manhattan Scientifics, Inc. PR& IRMarvin Maslow,
917-923-3300marvin@mhtx.comorSenior Scientifics,
LLCGerald Grafe,Presidentgerald@seniorscientific.comorFastnet
Advisors:Anthony Furey,
631-665-1234mtfurey@fastnetadvisors.comorHawk
Associates:Frank Hawkins,
305-451-1888f.hawkins@hawkassociates.comorEuropean
Contact:Herbert Strauss, +43-316-296-316herbert "at"
eu-ir.com
Manhattan Scientifics (PK) (USOTC:MHTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Manhattan Scientifics (PK) (USOTC:MHTX)
Historical Stock Chart
From Apr 2023 to Apr 2024